2012Hainan yixueRequires access

Clinical observation on the effect of Atorvastatin and Methycobal for diabetic peripheral neuropathy:a report of 64 cases

Qiu Hao-qian

Open publisher page 0 citations

Abstract

Objective To explore the effect of Atorvastatin and Methycobal for diabetic peripheral neuropathy. Methods 120 patietns with diabetic peripheral neuropathy were divided into the control group (treated with methycobal) and the study group (treated by atorvastatin and methycobal). The clinical effect, blood fat and nerve conduction velocity were compared between the two groups. Results After treatment, the levels of TG, TC and LDL in the study group were significantly lower than that in the control group (P0.01); the total effective rate were 92.2% and 83.9%, respectively, in the two groups, with statistically significant difference (P0.05); Nerve conduction velocity of common peroneal nerve and median nerve in the study group were superior to that in the control group (P0.05). Conclusion For patients with diabetic peripheral neuropathy, Atorvastatin and Methycobal can improve clinical symptoms and nerve conduction velocity.

About this research paper

What this paper is about

Objective To explore the effect of Atorvastatin and Methycobal for diabetic peripheral neuropathy. Methods 120 patietns with diabetic peripheral neuropathy were divided into the control group (treated with methycobal) and the study group (treated by atorvastatin and methycobal). The clinical effect, blood fat and nerve conduction velocity were compared between the two groups. Results After treatment, the levels of TG, TC and LDL in the study group were significantly lower than that in the control group (P0.01); the total effective rate were 92.2% and 83.9%, respectively, in the two groups, with statistically significant difference (P0.05); Nerve conduction velocity of common peroneal nerve and median nerve in the study group were superior to that in the control group (P0.05). Conclusion For patients with diabetic peripheral neuropathy, Atorvastatin and Methycobal can improve clinical symptoms and nerve conduction velocity.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of Atorvastatin and Methycobal for diabetic peripheral neuropathy. Methods 120 patietns with diabetic peripheral neuropathy were divided into the control group (treated with methycobal) and the study group (treated by atorvastatin and methycobal). The clinical effect, blood fat and nerve conduction velocity were compared between the two groups. Results After treatment, the levels of TG, TC and LDL in the study group were significantly lower than that in the control group (P0.01); the total effective rate were 92.2% and 83.9%, respectively, in the two groups, with statistically significant difference (P0.05); Nerve conduction velocity of common peroneal nerve and median nerve in the study group were superior to that in the control group (P0.05). Conclusion For patients with diabetic peripheral neuropathy, Atorvastatin and Methycobal can improve clinical symptoms and nerve conduction velocity.

Key concepts: Medicine, Atorvastatin, Nerve conduction velocity, Peripheral neuropathy, Peripheral, Median nerve, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on the effect of Atorvastatin and Methycobal for diabetic peripheral neuropathy:a report of 64 cases — Research Paper | ScholarLens